Troubled IRB closes shop

A company that serves as an independent review board for clinical trials and was caught approving a fake medical device study will close, the Wall Street Journal linkurl:reports.;http://online.wsj.com/article/SB124042341694744375.html The company, Colorado-based linkurl:Coast IRB,;http://www.coastirb.com/ was exposed in a government sting operation last month. Based on the undercover investigation's findings, the US Food and Drug Administration (FDA) sent Coast a formal reprimand on April 14 f

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A company that serves as an independent review board for clinical trials and was caught approving a fake medical device study will close, the Wall Street Journal linkurl:reports.;http://online.wsj.com/article/SB124042341694744375.html The company, Colorado-based linkurl:Coast IRB,;http://www.coastirb.com/ was exposed in a government sting operation last month. Based on the undercover investigation's findings, the US Food and Drug Administration (FDA) sent Coast a formal reprimand on April 14 for violating rules protecting clinical trial subjects. The FDA's action resulted in Coast freezing some of its key operations and promising to devise a plan to correct its shoddy practices by the end of the month. In a linkurl:letter;http://s.wsj.net/public/resources/documents/WSJ_Letter-Coast-employees-Board-Members_041709.pdf sent to employees and board members last week and posted today (April 22) by the WSJ, the company wrote that as a result of the FDA's letter, "several key customers have already pulled their studies from Coast IRB. Thus, it was determined that Coast IRB, LLC should immediately terminate all existing projects and transfer the studies to another IRB."
**__Related stories:__*** linkurl:FDA censures lax IRB;http://www.the-scientist.com/blog/display/55616/
[ 14th April 2009]*linkurl:Trial safety lacking, says GAO;http://www.the-scientist.com/blog/display/55546/
[26th March 2009]*linkurl:Subject death halts clinical trial;http://www.the-scientist.com/blog/display/54825/
[8th July 2008]*linkurl:Paying for patients;http://www.the-scientist.com/article/display/54196/
[February 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital
Concept illustration of acoustic waves and ripples.

Comparing Analytical Solutions for High-Throughput Drug Discovery

sciex

Products

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome

Magid Haddouchi, PhD, CCO

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer